Mice vaccinated with the O-antigen of Francisella tularensis LVS lipopolysaccharide conjugated to bovine serum albumin develop varying degrees of protective immunity against systemic or aerosol challenge with virulent type A and type B strains of the pathogen

Author： Conlan J.W.   Shen H.   Webb A.   Perry M.B.  

Publisher： Elsevier

ISSN： 0264-410X

Source： Vaccine, Vol.20, Iss.29, 2002-10, pp. : 3465-3471

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Tularemia in BALB/c and C57BL/6 mice vaccinated with Francisella tularensis LVS and challenged intradermally, or by aerosol with virulent isolates of the pathogen: protection varies depending on pathogen virulence, route of exposure, and host genetic background

By Chen W.   Shen H.   Webb A.   KuoLee R.   Conlan J.W.  

Vaccine, Vol. 21, Iss. 25, 2003-09 ,pp. : 3690-3700

Elsevier

Access to resources Recommend Favorite

Role of lipopolysaccharide and a major outer membrane protein from Francisella tularensis in the induction of immunity against tularemia

By Manchee R.   Titball R.   Fulop M.  

Vaccine, Vol. 13, Iss. 13, 1995-01 ,pp. : 1220-1225

Elsevier

Access to resources Recommend Favorite

Role of antibody to lipopolysaccharide in protection against low- and high-virulence strains of Francisella tularensis

By Fulop M.   Mastroeni P.   Green M.   Titball R.W.  

Vaccine, Vol. 19, Iss. 31, 2001-08 ,pp. : 4465-4472

Elsevier

Access to resources Recommend Favorite

Cross-protective efficacy of a bovine viral diarrhea virus (BVDV) type 1 vaccine against BVDV type 2 challenge

By Dean H.J.   Leyh R.  

Vaccine, Vol. 17, Iss. 9, 1999-03 ,pp. : 1117-1124

Elsevier

Access to resources Recommend Favorite

Onset and duration of protective immunity to IA/IB and IE strains of Venezuelan equine encephalitis virus in vaccinated mice

By Hart M.K.   Lind C.   Bakken R.   Robertson M.   Tammariello R.   Ludwig G.V.  

Vaccine, Vol. 20, Iss. 3, 2001-11 ,pp. : 616-622

Elsevier

Access to resources Recommend Favorite